Receive The Newest Study Notifications

The results of a randomized clinical trial conducted in the United Kingdom indicate that gentamicin is not a suitable alternative for ceftriaxone as part of first-line treatment for gonorrhea. But gentamicin combined with azithromycin might be appropriate for treating...

The costs and timelines to conduct clinical trials continue to increase, along with study complexity. While much of the focus within clinical trials has been on improving data integrity and overall study efficiency, addressing costs, timeline and complexity issues,...

Results of a first-in-humans trial presented at AATS 99th Annual Meeting indicates the safety of a novel treatment for ischemia reperfusion injury where none has existed to-date A new study, presented today at the American Association for Thoracic Surgery's 99th...

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that advances have been completed in the...

Verona Pharma plc (VRP.L) (VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of a Phase 2b dose-ranging study evaluating nebulized ensifentrine (RPL554) added on to a long acting...

SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that the first patient has been dosed in a Phase 1b study to evaluate the...

Trials to Evaluate the Safety, Tolerability and Preliminary Activity of Sensei’s SNS-301, in Combination with IMFINZI® (durvalumab), in Multiple Solid Tumor Types Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision...

A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing an innovative procedure that may provide hope in the fight against Alzheimer's disease. The non-invasive procedure uses low-intensity focused ultrasound to open the...

Genentech, a Roche company, presented data from its FIREFISH clinical trial of risdiplam in Type 1 spinal muscular atrophy (SMA) at the American Academy of Neurology Annual Meeting. The drug is an oral survival motor neuron-2 (SMN2) splicing modifier and is part of a...

Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on development of GABA A receptor modulators for neuropathic pain and other indications with unmet medical need, announced the appointment of Dr. Ingo Lehrke as CEO and Dr. Guido Koopmans as CSO,...

GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH,...

 Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that it has entered into a collaboration agreement with Eurofins Scientific...

The results of a new survey released last week at the 3rd Annual NASH (nonalcoholic steatohepatitis) Summit in Boston show that even among patients most at-risk for the fatty liver disease, awareness of the condition remains low. Global clinical trial enrollment...

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces completion of enrollment of the Company’s Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol program. The CE-Iohexol program is designed to develop a Captisol-enabled, next-generation...

A Chinese vaccine against the Hepatitis E Virus (HEV) has entered clinical trial in the United States after two U.S. volunteers were vaccinated on May 1 (local time), according to Xiamen University. The trial will be carried out in three phases. The phase 1 clinical...

First study of any kind showing a MIGS device achieving a statistically significant reduction in secondary incisional surgery; over 70% of patients remain free of medications Ivantis, Inc., developer of the novel Hydrus® Microstent, a micro-invasive glaucoma surgical...

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces completion of enrollment of the Company’s Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol program. The CE-Iohexol program is designed to develop a Captisol-enabled, next-generation...

-- Trial to evaluate effects of selective inhibitor of phosphodiesterase-4D on memory and cognitive measures -- Tetra Discovery Partners, a clinical-stage biotechnology company, today announced the initiation of a Phase 2 clinical trial (PICASSO AD) of BPN14770 in...

Topics will focus on phase I clinical trials in Australia at East Coast, U.S. locations PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services and commercial packaging to the global biopharmaceutical...

This clinical trial, which involved 12 patients with Parkinson’s disease, was conducted in collaboration with investigators from Royal Melbourne Hospital, a leading medical institution with an international reputation for excellence. Representative Image International...